128 related articles for article (PubMed ID: 26266132)
21. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.
Pereira H; Pinder SE; Sibbering DM; Galea MH; Elston CW; Blamey RW; Robertson JF; Ellis IO
Histopathology; 1995 Sep; 27(3):219-26. PubMed ID: 8522285
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine carcinoma of the breast with a mucinous carcinoma component: A case report with review of the literature.
Ishida M; Umeda T; Abe H; Tani T; Okabe H
Oncol Lett; 2012 Jul; 4(1):29-32. PubMed ID: 22807954
[TBL] [Abstract][Full Text] [Related]
23. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma.
Chen WY; Chen CS; Chen HC; Hung YJ; Chu JS
Pathol Int; 2004 Oct; 54(10):781-6. PubMed ID: 15482568
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period.
Ng WK
Cancer; 2002 Oct; 96(5):280-8. PubMed ID: 12378595
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53, DCC, and HER-2/neu in mucinous carcinoma of the breast.
Hsu YH; Shaw CK
Kaohsiung J Med Sci; 2005 May; 21(5):197-202. PubMed ID: 15960065
[TBL] [Abstract][Full Text] [Related]
26. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
[TBL] [Abstract][Full Text] [Related]
27. Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy.
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Nakahara S; Katsumoto F; Toyoshima S
Eur J Surg Oncol; 2001 Aug; 27(5):459-63. PubMed ID: 11504516
[TBL] [Abstract][Full Text] [Related]
28. Mucinous carcinoma of breast with psammomatous calcification: report of a rare case with extensive axillary metastases.
Bahadur S; Pujani M; Jetley S; Raina PK
Breast Dis; 2014 Jan; 34(4):177-81. PubMed ID: 24705517
[TBL] [Abstract][Full Text] [Related]
29. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
30. Invasive mucinous carcinoma arising within breast fibroadenoma.
Charfi L; Mrad K; Sellami R; Driss M; Sassi S; Abbes I; Ben Romdhane K
Pathologica; 2008 Jun; 100(3):199-201. PubMed ID: 18841829
[TBL] [Abstract][Full Text] [Related]
31. Mucinous breast carcinoma and mixed mucinous-infiltrating ductal carcinoma: a comparative cytologic study.
Stanley MW; Tani EM; Skoog L
Diagn Cytopathol; 1989; 5(2):134-8. PubMed ID: 2550188
[TBL] [Abstract][Full Text] [Related]
32. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
33. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
34. Imaging findings in mucin-containing carcinomas of the breast: correlation with pathologic features.
Conant EF; Dillon RL; Palazzo J; Ehrlich SM; Feig SA
AJR Am J Roentgenol; 1994 Oct; 163(4):821-4. PubMed ID: 8092016
[TBL] [Abstract][Full Text] [Related]
35. Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation.
Memis A; Ozdemir N; Parildar M; Ustun EE; Erhan Y
Eur J Radiol; 2000 Jul; 35(1):39-43. PubMed ID: 10930764
[TBL] [Abstract][Full Text] [Related]
36. Mucinous carcinoma of the breast: Diagnosis and management of an unusually young patient.
Achicanoy Puchana DM; Lasso Andrade FA; Achicanoy Puchana DF; Boada Fuentes MA; Álvarez Duarte MA; Angarita Acuña K; Jaime Aguirre AC; Muñoz Murillo JA; González Lago AM; Alegria Cuellar DA; Orozco Morales LK; Lasso Anacona MZZ; Alvarado Rengifo AE; Rosero Rosero JR
Radiol Case Rep; 2022 May; 17(5):1445-1449. PubMed ID: 35265238
[TBL] [Abstract][Full Text] [Related]
37. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.
Diab SG; Clark GM; Osborne CK; Libby A; Allred DC; Elledge RM
J Clin Oncol; 1999 May; 17(5):1442-8. PubMed ID: 10334529
[TBL] [Abstract][Full Text] [Related]
38. Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.
Rasmussen BB; Rose C; Hilkens J; Hilgers J
Virchows Arch A Pathol Anat Histopathol; 1986; 409(4):497-505. PubMed ID: 3016978
[TBL] [Abstract][Full Text] [Related]
39. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
40. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
